Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas.

Source:http://linkedlifedata.com/resource/pubmed/id/16718522

Download in:

View as

General Info

PMID
16718522